Chemoprevention in gastrointestinal adenocarcinoma: For few but not for all?

G. E. Bazuro, F. Torino, G. Gasparini, L. Capurso

Research output: Contribution to journalArticlepeer-review

Abstract

Despite the general progress of the last two decades in oncogenesis mechanism comprehension, in screening and surveillance programs, in technological support to diagnosis and in treatment protocols, the long-term survival of gastrointestinal (GI) cancer patients is not substantially changed. Therefore chemoprevention strategies still appear as a possible alternative to screening and surveillance programs in reducing the incidence and the mortality for GI cancer, at an acceptable cost/effectiveness ratio. The present review is focused on three GI cancers: esophageal adenocarcinoma, gastric cancer and colorectal cancer and their respective precarcinogenic lesions. The authors examine, for each neoplasia, the available chemopreventive agents, their mechanism of action in preventing cancer, the potential targets in the cell growth process, the cost/effectiveness ratio and, whenever present in literature, a comparison with other cancer prevention strategies. The authors conclude that, at present, with the available agents, chemoprevention is not indicated for all patients at low or moderate risk for GI cancer, and should not be considered as a substitute for endoscopic surveillance. In high-risk patients only, both chemoprevention and surveillance could be used. In future more specific agents and combined therapies should be tested in specific group of patients identified by their genomic susceptibility to develop cancer and responsiveness to therapy.

Original languageEnglish
Pages (from-to)429-444
Number of pages16
JournalMinerva Gastroenterologica e Dietologica
Volume54
Issue number4
Publication statusPublished - Dec 2008

Keywords

  • Chemoprevention
  • Gastrointestinal neoplasms
  • Outcome assessment (health care)

ASJC Scopus subject areas

  • Gastroenterology
  • Internal Medicine
  • Nutrition and Dietetics
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Chemoprevention in gastrointestinal adenocarcinoma: For few but not for all?'. Together they form a unique fingerprint.

Cite this